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Titanium implants are commonly used in the replacement of load bearing joints. 
Poor and slow initial integration of the titanium with the natural bone tissue is the major 
cause of long postsurgical healing and short life of an implant. This problem can be 
overcome by the use of biomimetic coatings made of naturally synthesised materials. 
Hydroxyapatite is the major mineral component of bone tissue and when applied as an 
implant coating it has shown improved enhancement of the new bone tissue formation. 
In addition biomolecules such as peptide aptamers, which have the ability to bind 
electrostatically to inorganic materials in ambient conditions, are currently being 
researched.  
In this research peptide FITC labelled peptide aptamers sequences made of 
titanium binding, hydroxyapatite binding motifs and hybrid peptides conjugating both 
sequences, were synthesized and characterized. They were then coated on Ti6Al4V 
and hydroxyapatite substrates. Fluorescence Microscopy have proved successful 
attachment of the molecules on the inorganic surfaces. Peptide release rates from the 
surface were measured in aqueous solutions at different temperatures and pH values, 
which mimic the different environments implants can be exposed. It was shown that the 
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1.  Introduction and Literature Review 
1.1 Joint Replacement 
Bone exhibits one of the most complex architectures produced by living organisms. It 
contains 70% of mineral calcium phosphate mostly in the form of hydroxyapatite and 
20% of organic materials.[1] The complex structure between the two phases is 
responsible for giving bone its mechanical properties such as fracture toughness, young 
modulus and strength. In the cases when these properties fail and defects are created, 
bone regenerates itself with the help of bone forming cells, such as osteoblasts, 
osteoclasts and osteocytes.[1] These cells are able to repair small defects of bone tissue 
but in the case of large defects, for example caused by arthritis or cancer, healing is very 
hard and sometimes almost impossible. The ability to regenerate also depends on the 
age and lifestyle of the person. For example when an individual is old, has diabetes or is 
a smoker the healing is much harder to achieve than in healthy younger people.[2] 
Instead the joints have to be replaced by a synthetic implant. In the UK the number of 
the load bearing joint replacement surgeries such as hip replacement and is growing 
every year. In 2011 there were 173,371 joint replacement surgeries performed in 
England and Wales, both in NHS and independent clinics, which is 9000 more than in 
2009.[3] In the USA the budget for the replacement surgeries was 32 billion US Dollars 
in 2004 and is expected to be 40 times larger in 2030.[1] Current implants last only 
between 15 to 20 years and then they have to be replaced.[1] These values show the 
growing need for the improvement of these implants in the future. 
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The load bearing joint replacement implants when introduced in the body should have 
biological and mechanical properties which will decrease the possibility of failing by both 
rejection of an implant by the body and implant mechanical failure. This is why bone 
substitutes should be osseoinductive and osseoconductive, the rate of its degradation 
should not be faster than the rate of formation of new bone which the implant is 
replacing. It should not be cytotoxic otherwise the osteoblasts will not be able to direct 
implant-bone integration. Its mechanical properties should be as close as possible to 
those of the natural tissue so that it will not break under the body weight or cause 
additional discomfort due to too much stiffness. So far creation of an ideal implant which 
has exactly the same biological, mechanical and chemical properties as bone, has been 
impossible to do. Ceramic bone minerals like hydroxyapatite (HAP) are bioresorbable 
and bioactive by promoting cell adhesion, but they are very brittle. Metals on the other 
hand have much better fracture toughness and strength but are bioinert and the 
osseointegration progresses slow. For hips and knees brittleness of ceramic materials 
such as HAP will lead to breaking of an implant so metals such as titanium are the 
material of choice. 
1.2 Bone-implant interface 
The most crucial time for the implant survival is the first two years after the 
replacement surgery. During that time fixation of the implant and its integration in the 
bone occurs,[1] so understanding the exact mechanism leading toward the 
osseointegration is important for the longevity of an implant. 
The first reaction of a body toward prosthesis is creating a conditioning film by 
adsorption of proteins on the implant surface and then cells on those proteins. [4, 5] The 
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adsorption of proteins happens via a combination of hydrogen binding, hydrophilic 
interactions and electrostatic interactions. The first two cases can lead to a change in 
protein tertiary structure and ultimately denaturation [6-8] so that the cells will not be 
able to attach, triggering a negative response. However, if the protein will be adsorbed 
via electrostatic interactions the conformation will not change and a positive signal for 
the osseoinductive cells adsorption will be observed.[7, 9, 10] 
The next step is filling in the gap between the implant and the bone. It has been 
observed, that the new bone formation on the implant surface precedes 30% faster than 
the one coming from the bone.[4] The observed bone growth from the implant toward 
the bone starts with the attachment of proteins such as Bone Sialoprotein (BSP) and 
Osteopontin (OPN) and osteoblasts to the implant surface initiate the deposition of the 
bone materials and from the bone toward the implant where the bone repair process 
occurs.[4] The new created structure which merges together the tissue and implant BSP 
and OPN have been found in large quantities,[4] it has been also shown that the 
expression of these two proteins has been significantly increased in new bone formation 
regions.[11] This leads to the conclusion that these two proteins contribute the most to 
the bone-implant integration. Therefore an implant structure that can increase the 
probability of specific proteins adsorption should be able to speed up the integration and 
decrease the risk of implant rejection.  
1.3 Titanium as implant material 
The titanium alloy Ti6Al4V is one of the most commonly used alloys for load bearing 
joint replacement. The mechanical properties as well as its low toxicity bring it on the top 
of list of the materials used in modern prosthetics. It is light weight, has great fracture 
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toughness and strength as well as good corrosion resistance and biocompatibility, 
compared to other metals.[7, 8] The mechanical properties of an implant are due to the 
metallic core, while the chemical properties such as toxicity and corrosion resistance are 
dictated by the passivation oxide layer which usually forms when the metal becomes in 
contact with air or water. The oxide film can be of several nm in thickness and consists 
of rutile (110) and anatase (101) planes.[9, 10] In aqueous solution some of the oxide 
layer becomes hydroxylated, due to dissociative adsorption of water, and gain 
amphoteric character as basic TiOH2
+ and acidic TiO- sites are formed.[12] Both the 
oxide and hydroxide can interact with biomolecules via hydrogen bonding, electrostatic 
and hydrophobic interactions.  
The attachment of Extra Cellular Matrix (ECM) biomolecules to the titanium surface is 
the trigger to start the osseointegration.[7, 9, 10] Proteins such as the Bone Sialoprotein 
attach themselves on the passivation layer attracting bone forming cells such as 
osteoblasts to spread on the implant surface and to initiate the new bone formation. If 
the surface of an implant with localized charge or hydrogen binding sites which are 
different that the one of ECM proteins, then the biomolecule which came in contact 
becomes denaturated due to the change in tertiary structure.[6-8] This negative 
response of protein to the surface significantly slows down the healing process and 
integration of an implant with the bone, by decreasing the amount of functional 
biomolecules on the surface of an implant.  
Various modifications of the titanium implant have been introduced to improve the 
biocompatibility and osseointegration. Change in surface roughness was proposed as a 
metallic implant improvement. In this concept porous surface of implant has possibility of 
interlocking an implant with the natural bone followed by of bone growth inside of the 
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irregularities.[4] Unfortunately, the in vivo studies showed little bone penetration in these 
pores [3] Another modification of an implant surface is acid etching where the acid in 
which the implant is immersed changes the chemistry of the surface of an implant. In 
these technique metal will develop more hydroxyl groups on its surface which are used 
by ECM entities such as proteins and cells, as sites for electrostatic binding and the 
initial stage of osseointegration.[4, 13] Another surface modification is applying coating 
on the surface by plasma spraying.[13] The material to be deposited is heated up to 
15000 K and sprayed molten on the surface. The new layer of coating introduces 
different chemistry due to a coating with different material such as oxide, which can 
attract ECM entities to bind. This technique is very energy consuming and the metal 
sprayed as well as the deposit is subjected to very high temperatures. Both plasma 
spraying and acid etching require very harsh conditions for the surface modification. The 
new chemistries are also not very selective towards the proteins and cells which will 
initiate the osseointegration and can attract unwanted entities such as bacteria. To 
increase the specificity of the surface of the implant, coating metal with material which 
resembles or mimics the one in the living organism represents an attractive strategy. 
Biomimetics is a study concentrated on designing materials, structures and reactions 
which mimic those existing in living organisms. Biomimetic materials can be both organic 
and inorganic, and because they are biomimetically derived from structures of natural 
tissues, they have greater probability of having positive response of Extracellular matrix 
entities. There are two different approaches in coating the metallic implant with 
biomolecules substrates for better integration.[4]  
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1.4 Improvement of coatings by applying biomimetic 
coatings 
For millions of years nature has been utilizing the biomolecules such as proteins and 
peptides to develop many complex structures of inorganic materials. All this is done in 
mild aqueous solution conditions of pH close to 7.0, 1 atm pressure and room or 
biological temperature. For some years now, the understanding on how this process is 
done and how can it be mimicked in the laboratory have been researched. 
Understanding of the functions of selected peptides would open a way to create the 
proteins which could be later used as a tool in medicine and other fields like material 
science.[14-17]  
Introduction of the peptide on the titanium can be done in two different ways 
depending on what the goal is. If positive cell response is the aim then the attachment of 
integrin binding sequences or growth factors are preferable.[18] At the moment, most 
studies are done with the RGD peptide sequence which binds to cell integrins.[19] This 
motif shows promising results in the study of cell attachment in vitro but unfortunately 
when introduced in the body it detaches itself from the surface of the implant due to 
weak binding interactions with the implant and results in no improvement of cell binding 
in vivo.[1, 18] Binding was improved by the covalent attachment of the RGD sequence 
to the surface, however this resulted in inhibition of bone growth.[5] It was proposed that 
this was due to a lack of specificity of RGD towards osteoblasts in vivo leading to 
unspecific protein attachment. The second approach involved the introduction of an 
organic layer on the inorganic implant surface by binding of molecules which are able to 
bind the hydroxyapatite. These molecules will induce creation of a hydroxyapatite 
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coating, which will be positively recognized by the osteoblasts and will result in 
attachment of those cells. 
Peptide aptamers are organic molecules which bind selected inorganic structures as 
well as biological moieties.[13, 20-24] These molecules are made of chains of different 
amino acids connected together with a peptide bond. The amino acids of the sequence 
allow for the electrostatic and hydrophobic interactions as well as hydrogen bonding, 
which contribute to attachment and binding functions. 
The sequences of peptides with binding abilities have been successfully found by the 
use of two methods.[21, 23, 24] Firstly, direct sequencing of native mineral binding 
proteins and the search for similar sequence domains. Peptides found this way bind to 
the natural minerals of specific crystalline structures but are limited to those which occur 
naturally. The second approach is based on combinatorial chemistry libraries such as 
phage display where viruses such as phages, are designed to express sequences of 
peptides on their head, then these phages are subjected to binding studies with defined 
materials. If the expressed peptide has an affinity toward the material, the phage will 
stay attached on its surface and can later be isolated and analysed to establish the 
peptide sequence. This method successfully led to finding peptide aptamers which 
usually are not expressed in the living organisms and bind towards many inorganic 
materials such as Ag, Pt, Cr2Co3, and TiO2. [23-25] 
1.4.1 Titanium binding peptide 
Sano and Shiba used phage display to find a 12-mer peptide which specifically binds 
to titanium. They created a peptide phage library that encodes peptides with diversity 
~2.7x109 and subjected them for binding studies with titanium particles.[8]. In Sano and 
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Shiba research, phages which were attached to the surface of the titanium were 
identified and they found that the sequence RKLPDAPGMHTW (Arg-Lys-Leu-Pro-Asp-
Ala-Pro-Gly-Met-His-Tyr-Trp) had the strongest adsorption toward this metal.[26] To 
predict the nature of the attraction and to test which amino acid is responsible for the 
interaction with the surface they made phages with alanine substituted for each of the 
amino acid of the sequence. This substitution showed that only the first six N-terminal 
residues RKLPDA, later named minTBP-1, take part in the binding and that the R1, P4 
and D5 are crucial.[26] It is well known that the peptide aptamers use electrostatic 
interactions to bind to other substrates.[15, 17, 20, 23, 27-29] It is also known that the 
titanium interfacial layer in aqueous solution is amphoteric due to the hydroxylation of 
oxide. [7] Based on these findings Sano and Shiba proposed a binding model where 
positively charged arginine binds with the TiO- while the negatively charged aspartic acid 
binds with the TiOH2
+. This finding is similar to that of Roddick-Lanzilotta et al. and the 
binding of lysine, glutamic and aspartic acids to the titanium surface.[9, 10] The role of 
proline on the other hand was proposed to be responsible for the right conformation of 
the bend so the two amino acids can both get into contact with the consecutive 
hydroxylated surface.[8]  
Table 1.1 Examples of peptide sequences able to bind the titanium 
Peptide name Peptide sequence Reference 
STB-1 HKKPSKS [30] 
TiBP-1 RPRENRGRERGL [31] 
R5 SSKKSGSYSGSKGSKRRIL [20] 
 
The binding between the peptide and the surface can be affected if it is coupled to 
another molecule. The ability to retain its function when integrated with another species 
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was tested by grafting minTBP-1 to proteins like ferritin[6, 32], BMP-1[18] as well as with 
RGD sequences[33]. In all cases, besides the binding with BMP-1, significant adsorption 
of sequences has been observed. The failure in BMP-1 attachment was explained by 
expression of too small amounts of minTBP-1 for this this protein which has extremely 
large molecular weight in comparison with the binding ability of the peptide sequence. 
This didn’t affect the ferritin as more minTB-1s were coupled to it. The ability to be 
coupled to other molecules shows that the peptide can be used for polypeptides with 
specifically designed motifs or proteins which will have great impact on bioengineering 
and especially improvement of implant biocompatibility.  
It is often observed that the peptide aptamers bind to more than one inorganic surface, 
although in some cases the selectiveness towards only one moiety is noticed. Sano et al. 
tested the selectivity of the TBP peptide and found that it binds to the Ti, Ag and Si 
particles with the preference toward Ti, and it does not bind to Fe, Pt, Sn, Zn Cu, and Cr 
[25]. The preference is not well understood since all of the tested materials are covered 
with the passivation film, but it has been proposed that the spacing of the titanium oxide 
plays a significant role. 
1.4.2 Hydroxyapatite binding peptide 
Bone is made of collagen fibres and hydroxyapatite (Ca10(PO4)6OH2, HAP) attached 
to them. The collagen is not able to initiate nucleation of the HAP, [34, 35] so other 
proteins from the ECM such as BSP and OPN control this process.[35] It is well 
established, that the bone forming proteins possess a large amount of negatively 
charged residues, such as glutamic acids, aspartic acids and phosphoserines.[36] 
Based on this, it has been proposed that these acidic motifs are major factors for the 
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hydroxyapatite crystal formation.[34] The exact process in which these molecules are 
able the initiate the synthesis is not known but based on the fact that they all have acidic 
character, it was proposed that the positively charged calcium ions suspended in the 
Extracellular Matrix will be attracted to them.[11, 34, 37, 38] This will create highly 
positive sites and cause the negatively charged phosphate ions to neutralize the calcium 
ions leading to the nucleation of calcium phosphate and further maturation of the 
crystals to HAP due to the appropriate spatial arrangement of amino acids. [34, 36] 
Protein sequencing and analysis has yielded many sequences which have the ability 
to nucleate the HAP formation. BSP has been observed to exist in the bone-implant 
interface layer in large quantities,[4] its expression is also increased in the de novo bone 
forming areas.[11] This leads to the conclusion that it is a major component of the new 
bone formation and of implant early integration. This protein is negatively charged due to 
repeats of the glutamic acids.  
Table 1.2: Examples of peptide sequences able to bind to HAP 
Peptide name Peptide Sequence Reference 




E8 EEEEEEEE [40] 
 
A highly negative oligoglutamic motif is conserved in mammalian BSP. Quantum 
calculations, performed by Sahai,[41] of the arrangement of calcium ions, phosphate 
ions and oligoGlu’s carboxylates showed the arrangement similar to that of the (001) 
face of HAP. The Molecular Dynamic studies on the conformation effect of the peptide 
on Ca/P formation was further studied by Sahai et al.[11] In this research it was shown 
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that the oligoGlu is able to form an α-helix in solution containing calcium and phosphate 
ions, this causes the formation of equilateral triangle Calcium and Phosphate 
arrangement typical for HAP crystals hence the nucleation of HAP. If a random coil is 
observed, the spatial arrangement is not present an amorphous calcium phosphate is 
formed.[11] Sahai also reported that the equilateral triangle can be observed when the n, 
n+4 and n+7 negatively charged amino acids are involved in the calcium ions binding 
and that this amino acid sequence might form helix which will spatially arrange the 
crystals of calcium phosphate into HAP form [11]. 
Peptides with nucleating abilities toward certain materials are also able to bind to 
them. Sawyer confirmed this property for the oligoglutamic acid sequence. In his 
research, he conjugated the FITC labelled E7 with the RGD sequence, and bound this 
structure on HAP.[42] Fluorescence microscopy as well as Enzyme-linked 
immunosorbent assay (ELISA) confirmed the peptide coating on the surface of the HAP 
disc proving the binding ability of the OligoGlu sequence on the HAP surface. The 
research done by Wang et al. on conjugation of E8 in the polymer substrate also proves 
the binding ability of this small motif towards the HAP.[43] 
1.5 Aims and Objectives 
The aim of this project is to create a peptide based coating which will have a potential 
to link the bioceramic material with the titanium alloy implant. In order to do so 
sequences are designed to be made of various arrangement of two peptide aptamer 
motifs: titanium binding peptide (minTBP) and hydroxyapatite nucleating sequence (E8). 
This two aptamers were previously proven to be able to establish electrostatic 
interactions with respectively HAP and Ti6Al4V. Also these designed peptide 
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summarised in the Table 1.3 are synthesized and analysed in terms of purity, uniformity 
of the coating on the respective stability on the surface in the environments which can 
occur during the postsurgical wound healing.  
Table 1.3 Synthesized peptide sequences with the function of titanium and/or HAP 
binding. The titanium binding domain is underlined with a blue colour and HAP binding 
domain is underlined with a red colour. 
Peptide  Peptide sequence 
minTBP RKLPDA 
FITC labelled minTBP (FITC)-Ahx-RKLPDA 
E8 EEEEEEEE 
FITC labelled E8 (FITC)-Ahx-EEEEEEEE 
minTBPE8 RKLPDA-Ahx-EEEEEEEE 
FITC labelled minTBPE8 (FITC)-Ahx-RKLPDA-Ahx-EEEEEEEE 
E8minTBP EEEEEEEE-Ahx-RKLPDA 
FITC labelled E8minTBP (FITC)-Ahx-EEEEEEEE-Ahx-RKLPDA 
minTBPminTBPE8 RKLPDA-Ahx-RKLPDA–Ahx-EEEEEEEE 
FITC labelled minTBPminTBPE8 (FITC)-Ahx-RKLPDA-Ahx-RKLPDA–Ahx-
EEEEEEEE 
minTBPminTBP RKLPDA-Ahx-RKLPDA 
FITC labelled minTBPminTBP (FITC)-Ahx-RKLPDA-Ahx-RKLPDA 
 
They are then analysed in terms of their composition, coating distribution and release 
from the inorganic surfaces at different pH values and temperatures relevant to wound 
healing and implant conditions. The determination of whether the peptide is able to 
establish binding with the inorganic surface and how fast the peptide is released from 
the surface is then investigated. 
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Chapter 2  
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2. Materials and Methods 
2.1 Materials 
All of the Fmoc protected amino acids, amino acid preloaded Wang resin beads 
(loading 0.21 - 5.3 mmol) and O-benzotriazole-N,N,N’,N’-tetramethyl-uronium-
hexafluoro-phosphate (HBTU) used in Solid Peptide Phase Synthesis (SPPS) were 
purchased from NovaBiochem, UK. All of the amino acids had purity of >98% and were 
obtained with N-terminal Fluorenylmethyloxycarbonyl (Fmoc) protecting group as well as 
with side chain protecting groups where appropriate. Amino acids and resin beads which 
were obtained, were Fmoc-Ala-OH, Fmoc-Ala-Wang (loading 0.33 mmol/g), Fmoc-
Arg(Pbf)-OH, Fmoc-Asp(OtBu)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Glu(OtBu)-Wang 
(loading 0.32 mmol/g),  Fmoc-Gly-OH, Fmoc-Gly-Wang (loading 0.78 mmol/g) , Fmoc-
Leu-OH, Fmoc-Lys(Boc)-OH and Fmoc-Pro-OH. The solvents and reagents used for 
SPPS were: anhydrous dichloromethane (DCM), anhydrous N,N-dimethylformide (DMF), 
N,N-diisopropylethylamine (DIPEA), fluorescein isothiocyanate (FITC), piperidine, 
ninhydrin as well as cleavage cocktail components: trifluoroacetic acid (TFA) and 
triisopropylsilane (TIPS). All of the above were purchased from Sigma-Aldrich, were of 
HPLC grade and they were of >99% purity. Acetonitrile used for the High Pressure 
Liquid Chromatography (HPLC) was purchased from Sigma-Aldrich, was 
CHROMASOLV® gradient grade and was of ≥ 99.9% purity. Anhydrous diethyl ether of 
HPLC grade used for the precipitation of peptides was purchased from Fisher Scientific, 
UK. Aldrich® System 45™ vessels with cap and fritted disc were used as the reaction 
flasks during the Solid Phase Peptide Synthesis (SPPS) and were purchased from 
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Sigma-Aldrich. The Tris Buffer Saline (TBS) 50 mM, pH 7.6 at 24 oC and 150 mM NaCl 
tablets were used for dissolving peptides and were purchased from Sigma-Aldrich. The 
Phosphate Buffer Saline (PBS) 10x, pH 7.4, 100 mM NaCl tablets used for dissolving 
peptides was purchased from Sigma-Aldrich and they were then diluted with deionized 
water to the 1M concentration prior to use. Hydroxyapatite (HAP) was made in house 
following a well-established synthesis route. [44] The titanium alloy substrate was of 
grade 5 and was supplied by William Gregor Ltd. The polishing plates MD-Piano 220, 
MD-Largo and MD-Chem used as well as the 9 µm diamond suspension and the 
colloidal silica (OP-S) were purchased from Struers Ltd. 
2.2 Peptide Synthesis 
Peptides are synthesised when an amide bond (also known as peptide bond) is 
formed between an amine group (N-terminal) of one amino acid and a carboxylic acid 
group (C-terminal) of a second amino acid. A simplified peptide bond formation reaction 
is shown in Figure 2.1, where R1 and R2 represent different side chain groups.  
 
Figure 2.1: Simplified representation of a peptide bond formation between the C-terminal 
of an amino acid with R1 side chain and the N-terminal of a second amino acid with R2 
side chain. 
 
Each amino acid is able to react both its N- and C-terminal; this means that the 
synthesized products of the mixture of amino acids with side chains of R1 and R2 will be a 
mixture of dipeptides: R1R2, R2R1, R1R1 and R2R2. In addition, when excess of amino 
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acids are available, longer peptides chains can be formed by joining the di-peptides 
together. The sequence is controlled by the protection of the C-terminal of the first amino 
acid and the N-terminal of the second amino acid, as well as capping the side chain 
reactive groups with appropriate protecting groups.[45]  Each protecting group can be 
cleaved with different reagents. When all of the above conditions are satisfied, peptides 
of a good purity can be obtained and produced in good yields. 
In this research Fluorenylmethyloxycarbonyl (Fmoc) based Solid Peptide Phase 
Synthesis (SPPS) was performed to ensure purity and yield. In this method, resin beads 
are linked via ester bonds to the carboxylic acids of an amino acid, while the amine 
groups are protected with an Fmoc group.[45] The Fmoc is cleaved with base, usually 
piperidine, while the resin and side chain protecting groups are cleaved with 
trifluoroacetic acid (TFA).[45] SPPS is a one-pot-synthesis where amino acids are added 
to the sequence one at a time from the peptides C-terminal towards the N-terminal. The 
maximum purity of each reaction step is achieved by thorough washing off the excess 




Figure 2.2: Schematic representation of the deprotection and coupling steps performed 
during Solid Phase Peptide Synthesis. [45] 
2.2.1 Deprotection of Fmoc group from N-terminal of amino acid 
Cleavage of the Fmoc protection group was performed with the piperidine and the 
mechanism of reaction is shown in Figure 2.3. Piperidine in DMF (2 mL, 1:5 v: v) was 
added into the reaction vessel, on the resin beads which were earlier swollen for 1 h in 
2-3 mL DMF. The vessel was tightly closed and placed on the orbital shaker. The 
reaction solution was left to react for 30 minutes under continuous shaking with 
frequency of 200 rpm. Then the reaction solution was discarded by vacuum filtration and 
the resin beads, as well as the flask walls were washed three times with DMF (3 mL), 
three times with DCM (3 mL) and again three times with DMF (3 mL) to ensure that no 




Figure 2.3: Schematic representation of mechanism in deprotection of the Fmoc 
protection group. [45] 
2.2.2 Amide bond formation during Solid Phase Peptide 
Synthesis 
Coupling of the amino acids does not take place spontaneously at ambient 
temperature so coupling reagents such as O-benzotriazole-N,N,N',N'-tetramethyl-
uronium-hexafluoro-phosphate (HBTU) and diisopropylethylamine (DIPEA) are 
introduced to activate the carboxylic acid by forming reactive intermediates.[46] 




Figure 2.4: Mechanism of peptide bond formation with the use of the HBTU.[45] 
 
The carboxylic acid of the peptide forms an active ester with the HBTU in the 
presence of DIPEA. The ester bond is later substituted for the amine of an amino acid 
forming peptide bond. 
When the sequence is finished, beads with protected the protected peptide are 
exposed to a mixture of TFA which will cleave the ester bond between peptide and the 
resin as well removing the side chain protecting groups. The time of this reaction is 
crucial to achieve good yield of the product as well as good purity. If the reaction takes 
place too short the deprotection of the side chain groups will not be finished and the 
purity will be low.[45]  
In this research, the resin beads used were purchased already preloaded with the 
Fmoc-amino acids and the loading of the resin was between 0.21 - 5.3 mmol. The first 
step performed was cleavage of the Fmoc group using piperidine followed by washing, 
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and coupling the deprotected amine group with the second amino acid. Peptide 
sequences synthesized during SPPS synthesis are summarized in the Table 2.1 all of 
the peptides were also fluorescence labelled at the end of the synthesis with the 
fluorescein isothiocyanate (FITC). 
Table 2.1: Peptides synthesized by Solid Phases Peptide Synthesis method.  








The 6-Aminocaproic acid (Ahx) spacer was added to decrease the impact of the bulky 
fluorescein isothiocyanate (FITC) on the function of the peptide sequence. During the 
procedure the amount of the reagents added was based on the molar loading of resin 
beads and the amounts of the reagent is described as the equivalents (eq.). Fmoc-
amino acid (5 eq.) HBTU (4.9 eq.) and DMF (2 mL) were added into a clean test tube, 
mixed with a vortex mixer and left to react for 5 min. Next, DIPEA (10 eq.) was added 
into the mixture; the solution was mixed with a vortex mixer and transferred to the vessel 
with deprotected, washed resin beads. Then resin beads and the amino acid containing 
solution were left to react with shaking (2 h – 3.5 h). Ninhydrin test was used to 
determine if peptide couplings were complete and it was performed after 2 h of coupling 
reaction. The test was performed by transferring a small amount of resin (~10 beads) 
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into a test tube with the solution of ninhydrin in water (2 mL, 1:100 w:v) followed by 
heating for 3 minutes. No colour change or brown colour of beads after 3 minutes of 
boiling the solution was an indication of complete coupling, while blue coloured beads 
was an indication of incomplete coupling. The ninhydrin test was not performed during 
coupling of leucine with proline because colour change is not observed when secondary 
the amine of proline is present. 
After the coupling reaction was completed the solution in the reaction vessel was 
discarded and the resin beads as well as the flask walls were washed three times with 
DMF (3 mL), three times with DCM (3 mL) and again three times with DMF (3 mL). The 
wash step was followed by deprotection and coupling with the next amino acid as 
described above till the entire sequence was synthesized. 
The resin beads containing complete sequences were dried under vacuum, weighted 
and one half of the resin was FITC labelled and the rest was cleaved from the resin. 
2.2.3 FITC labelling of the peptide sequence 
The part of the resin beads designated for fluorescence labelling were swollen in 
DMF (2 mL, 1 h) and reacted with piperidine in DMF (2 mL; 1:5 v:v) for 30 minutes under 
shaking conditions on an orbital shaker with the frequency of 200 rpm. Then the solution 
was discarded and the beads were washed three times with DMF (3 mL), three times 
with DCM (3 mL) and again three times with DMF (3 mL). Fmoc-Ahx-OH (5 eq.) was 
added to a test tube and preactivated for 2 minutes in a solution of HBTU (4.9 eq.) 
dissolved DMF (2 mL) and mixed with a vortex mixer. Then DIPEA (10 eq.) was added 
and the liquid was mixed again. This solution was then transferred to the resin and 
reacted with shaking for 1-2 hours depending on results from the ninhydrin test as 
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described above. When the coupling reaction was completed, the solution was 
discarded with vacuum filtration and resin beads, as well as the flask walls, washed 
three times with DMF (3 mL), three times with DCM (3 mL) and again three times with 
DMF (3 mL). In a test tube fluorescein isothiocyanate (2 eq.) was dissolved in DMF 
(2 mL) and DIPEA (16 eq.) was added to the solution. This liquid was then transferred to 
the resin beads and left to react overnight with shaking of 200 rpm frequency. The FITC 
is prone to photo bleaching so the vessel was shield from the light with aluminium foil 
during the reaction. Reaction progress was monitored with ninhydrin test as described 
before. When no primary amines were detected the resin beads were washed four times 
with DMF (3 mL) and four times with DCM (3 mL) and then dried under vacuum for 
15 min. 
2.2.4 Cleavage of peptide from the resin and deprotection of 
amino acid side chains. 
The separation of the peptides from the resin beads as well as the deprotection of the 
side chain protection groups of amino acids were performed with the following steps. 
A cleavage mixture of the trifluoroacetic acid (TFA), deionised water and 
triisopropylsilane (TIPS) (95:2.5:2.5, v: v: v) was prepared fresh for each cleavage 
reaction. Dried resin beads were placed in a round bottom flask followed by addition of 
the cleavage solution (10 mL per 0.1 g of dried resin). The flask was closed with a 
stopper and the solution was left to react with gentle stirring for 3 hours. Flasks with the 
FITC labelled peptides were additionally wrapped in aluminium foil to prevent the access 
of light.  
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2.2.5 Precipitation of peptides 
Resin beads were removed by filtration and the filtrate was added dropwise to ice 
cold diethyl ether resulting in precipitation. The ether solution was then kept overnight at 
-20 oC to ensure complete precipitation. The peptide solid was then separated from the 
supernatant by centrifugation at 13,500 rpm for 3 minutes inside an Eppendorf test 
tubes and then air dried overnight at -20 oC. All peptides were stored at -20 oC. 
2.3 Peptide Characterization 
2.3.1 Mass spectrometry 
Peptide sequences were analysed by Electrospray Mass Spectrometry. On a 
Micromass LCT instrument by the School of Chemistry Mass Spectrometry facility.  
2.3.2 High Pressure Liquid Chromatography 
The purity of crude peptide products was evaluated using High Pressure Liquid 
Chromatography (HPLC) on analytical Dionex Summit equipment and was recorded in 
School of Chemistry. In this technique molecules are separated based on their 
hydrophobicity by using the octadecyl carbon (C18) chain bonded to the silica as the 
stationary phase and the mobile phase made of a gradient of solvents, in this case water 
with 0.05 % TFA 100 % acetonitrile with 0.05% TFA. The eluted molecules were 
detected by measuring the UV absorbance at λ = 210 nm, which corresponds to the 
absorption of the peptide bond. 10 µL of peptide dissolved in water was injected onto an 
analytical HPLC column and the column was run for 60 minutes with the linear solvent 
gradient where the 100% of water and 0% of acetonitrile was used at the starting time 
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and 40% water 60% of acetonitrile was used after 60 min. With the increase of the 
organic solvent, more hydrophobic molecule were eluted from the column. Purity was 
based on integration of peaks areas 
2.4 Ti6Al4V and HAP plate preparation and coatings 
2.4.1 Preparation of Ti6Al4V plates 
Titanium alloy substrates of 1 cm width, 1 cm length and 0.1 cm thickness were 
moulded in the conducting Bakelite and polished to a mirror finish on the automatic 
polishing machine. Three polishing discs were used to polish Ti6Al4V plates. First 
MD-Piano 220 discs with water as a lubricant was used, than MD-Largo disc with 9 µm 
diamond suspension followed by MD-Chem disc with ammonia activated colloidal silica 
with hydrogen peroxide (30%) mixture (OP-S). After polishing, plates were cut out of the 
conducting Bakelite and were cleaned with ethanol and placed in deionised water 
overnight. During this time a titanium oxide layer was formed which reacts with water to 
form hydro-complexes. Prior to coating with the peptides, plates were ultrasonically 
cleaned in acetone in ultrasonic bath (15 min) followed by rinsing with deionised water 
followed by ultrasonic cleaning in deionised water (15 min). Samples were then dried in 
air at room temperature for 1 h. 
Titanium alloy substrates were also polished with the carbide paper 400 grit to see if 
the surface roughness has an effect on the attachment of peptide molecules.  
The Ti6Al4V substrates polished to the mirror finish were also treated with the 
hydrogen peroxide (H2O2) to see if the change if this chemical treatment will induce 
better binding to the surface of the metallic substrates. The each titanium plate was 
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immersed in 4 mL of 42% hydrogen peroxide and was left to react for 12 h. Afterwards it 
was rinsed three times with deionised water and it was coated with the peptide 
immediately. 
2.4.2 HAP discs preparation 
HAP was prepared from solutions of calcium nitrate tetrahydrite (Ca(NO3)•4H2O)  and 
ammonium phosphate ((NH4)2HPO4), by a well-established method.[47] At first 102 g of 
Ca(NO3)•4H2O was dissolved in 400 mL of deionized water, the pH value was adjusted 
to 10 with 5 M ammonium hydroxide (NH4OH) and solution was heated up till 90 
oC. 
Then 24 g of (NH4)2HPO4 were dissolved in 400 mL of deionized water and pH value of 
solution was adjusted to 10 with 5 M NH4OH. Then (NH4)2HPO4 solution was titrated into 
the flask equipped with condenser and containing solution of Ca(NO3)•4H2O heated to 
90 oC. Mixture was left to react for 5 hours at 90 oC with constant stirring and reflux. 
Then solution was placed overnight in the oven at 37 oC to achieve mature HAP crystals. 
The pellet was separated from the supernatant by centrifugation for 10 min at 
10000 rpm. The precipitate was then washed three times by resuspending it in 
deionized water followed by centrifugation for 10 min at 10000 rpm. The obtained HAP 
was then place in the oven at 60 oC until dry. Dried HAP was then grinded with mortar 
and pestle and compress on the 30 kN load cell into discs (1 cm diameter, 0.7 g) with 
compression speed of 4 mm/min. The discs were then sintered at 1100 oC for two hours 
with the heating and cooling rate of 4 oC per minute. Discs were cleaned before use in 




Hydroxyapatite (0.5 g) was compressed in a cylindrical dye (1 cm in diameter) with 
the 5.0 kN maximum load. Then the pellets were placed in the oven, and heated to the 
sintering temperature of 1100 oC at a rate of 10 oC per minute. When this temperature 
was reached they were sintered for 2 h followed by cooling down to 70 oC at a cooling 
rate of 10 oC per minute. 
2.4.3 Measurements of the surface roughness of HAP and 
Ti6Al4V 
The surface roughness of sintered HAP discs and differently treated titanium plates 
were tested with contact surface roughness analyser (Surtronic 3P, TaylorHobson, UK) 
set up to measure 99.99 µm range, at 2.5 mm cut off. For analysed substrate six 
measurements were taken over different points of the surface of a metallic plate. Data 
were collected in triplicate. 
 
2.4.4 Coating of HAP discs and Ti6Al4V plates surfaces with 
peptide solutions 
Peptides were dissolved in PBS to the final concentration of 100 μg/mL. The plates 
and discs were placed in 24 well cell culture plates one plate or disc per well. Then a 
drop (0.5 mL) of peptide solution was dropped on inorganic surfaces and was left to bind 
for 30 minutes. After this time inorganic surfaces were rinsed three times with deionized 
water and were air dried. 
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2.4.5 Fluorescence studies 
Surfaces of HAP and Ti6Al4V coated with FITC labelled peptides were analysed 
under the Nikon fluorescence microscope in the Medical School fluorescence 
microscopy facility. The Microscope was equipped with a mercury-vapour lamp with UV 
emission wavelength of 488 nm and a peak emission measured at 525 nm with the FL1 
channel. This emission corresponds to the FITC green fluorescence light emission. 
Three images of each surface were recorded for comparison. ImageJ 1.46r program 
was used to splitting image into red, blue and green channels. Only the channel green 
was analysed in terms of grey value as FITC fluorescence is observed as green.  
2.5   Release studies of peptides from the surface of HAP 
and Ti6Al4V at different temperatures and pH values. 
HAP discs coated with E8, minTBPE8, E8minTBP and minTBPminTBPE8 FITC 
labelled peptides as well as Ti6Al4V plates coated with minTBP, minTBPE8, E8minTBP, 
minTBPminTBP and minTBPminTBPE8 labelled peptides were placed one disc per well 
in the 24 well cell culture plates. Each inorganic material coated with peptides was 
placed at either 24 oC, 37 oC or 44 oC, pH 7.4 in 2 mL of PBS or at 37 oC for the 
temperature dependant release or in 2 mL of sodium acetate buffer pH 5.2, PBS pH 7.4 
and phosphate buffer pH 10.0 at a constant temperature of 37 oC. 50 μL of solution was 
taken out from each well after 15 min, 30 min, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 24 h, 27 h and 
30 h.  Aliquots were placed in a 96 well cell plate and analysed with a fluorescence 
microplate reader. The excitation wavelength of 488 nm and FITC light fluorescence 
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emission was detected at 518 nm. Each release study of peptide was done in triplicate 
for each temperature and pH value. 
By mistake the temperature for the 44 oC samples was increased to 60 oC for a period 
of 15 minutes between the 4 and 5 hour measurement.  
The amount of the molecules bounded on the surface was not controlled and can 
vary from one substrate to another. The impact caused by difference in amount of 
molecules attached to the substrate was accounted for by dividing each fluorescence 
intensity data by the highest intensity achieved for a given set. The normalized fractions 
were then averaged and graphed on a diagram. 
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3.1 Solid Phase Peptide Synthesis 
Purity of peptides synthesized during the Solid Phase Peptide Synthesis (SPPS) as 
well as the theoretical mass and mass observed with the Mass Spectrometry are 




















Table 3.1: Purity and Mass Analysis of each synthesized peptide sequence. 













(FITC)-Ahx-RKLPDA 1201.4  [M+2H]2+ - 601.2 81% 
E8 EEEEEEEE 1050.9 [M+H]+ - 1051.2 87% 
FITC labelled E8 
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3.2 Surface roughness measurements of HAP and Ti6Al4V 
Average surface roughness (Ra) of mirror finish polished, carbide paper grit 400 
polished and H2O2 pre-treated Ti6Al4V plates are summarized in Table 3.2. 
Table 3.2: Surface roughness measured for the surfaces of HAP and Ti6Al4V, n = 5. 
Surface Surface roughness (Ra) [µm] 
HAP 1.52 ± 0.30 µm 
Mirror finish polished Ti6Al4V 0.03 ± 0.01 µm 
Carbide paper grit 400 polishing 0.77 ± 0.22 µm 
H2O2 pre-treatment 1.16 ± 0.16 µm 
 
3.3 Characterizations of the peptide coatings on the surface 
of the inorganic substrates 
FITC labelled peptides coated on the surfaces of HAP and Ti6Al4V were observed 
under the fluorescence microscopy at the magnification of 10 x (if not specified 
otherwise) and using 10 ms or 200 ms camera exposure respectively. Longer exposure 
time was needed for the metallic substrate was needed because, FITC fluorescence 
was not observed for 10 ms exposure.  
Images of FITC labelled peptide coated surface of hydroxyapatite, Ti6Al4V polished 
to the mirror finish, Ti6Al4V polished with carbide paper and Ti6Al4V treated with the 
hydrogen peroxide are shown in this section. Grey value intensity distribution across the 




3.3.1 Fluorescence microscopy image of the FITC labelled 
peptides on the surface of HAP. 
Figure 3.1 -Figure 3.5 show fluorescence images as well as the corresponding grey 
value intensity distribution of E8, E8minTBP, minTBPE8 and minTBPminTBPE8 coated 
on HAP discs as well as controls prepared with the HAP and PBS buffer. The grey value 
distribution shows uniform coating with some darker regions which are due to the porous 
surface of hydroxyapatite. 
 
 
Figure 3.1: a) Fluorescence microscopy image of HAP control and b) gray value 
distribution of the imaged surface.  
 
 
Figure 3.2: a) Fluorescence Microscopy image of HAP coated with the E8 peptide and b) 








Figure 3.3: a) Fluorescence Microscopy image of HAP coated with the minTBPE8 peptide 
and b) gray value distribution of this molecule across the imaged surface. 
 
 
Figure 3.4: a) Fluorescence Microscopy image of HAP coated with the E8minTBP peptide 










Figure 3.5: a) Fluorescence microscopy image of HAP coated with the minTBPminTBPE8 
peptide and b) gray value distribution of this molecule across the imaged surface. 
 
Mean of grey values of imaged surfaces of all the peptides is summarized in 
Figure 3.6. It was observed that HAP surface coated with the E8 peptide on its own has 
the greatest intensity out of all the peptides which indicates that this peptide bounded on 
the surface in the greatest amount. The second greatest intensity was observed for 
minTBPE8 peptide which has the oligoglutamic acid rich motif at the C terminal of the 
peptide. E8minTBP which has a third greatest grey value mean intensity has the E8 
group between the FITC-Ahx labelling and the minTBP peptide. MinTBPminTBPE8 was 
observed to have the smallest intensity out of all of the peptides. This peptide has the 







Figure 3.6: Mean grey value intensities of HAP surface coated with peptides. Error bars 
designate standard deviation for n = 3. 
3.3.2 Fluorescence microscopy of the FITC labelled peptides on 
the surface of mirror finish polished Ti6Al4V 
Figure 3.7 Figure 3.12 show fluorescence images as well as the corresponding grey 
value intensity distributions of minTBP, E8minTBP, minTBPE8, minTBPminTBP and 
minTBPminTBPE8 coated on mirror finish polished Ti6Al4V plates as well as buffer 
control. The distribution for all of these molecules was not uniform across the surface. 
Each of the peptides showed aggregation either in form of crystalline-like arrangements 




















Figure 3.7: Fluorescence microscopy image of the buffer coated control of mirror finished 
polished Ti6Al4V  
 
Figure 3.8: Fluorescence microscopy image of mirror finished polished Ti6Al4V coated 
with the minTBP. 
 
Figure 3.9: Fluorescence microscopy image of mirror finished polished Ti6Al4V coated 




Figure 3.10: Fluorescence microscopy image of mirror finished polished Ti6Al4V coated 
with E8minTBP peptide. 
 
Figure 3.11: Fluorescence microscopy image of mirror finished polished Ti6Al4V coated 
with minTBPminTBP peptide. 
 
Figure 3.12: Fluorescence microscopy image of mirror finished polished Ti6Al4V coated 




The patterns of the peptide clusters are not similar. MinTBP forms four arm star like 
shapes, minTBPE8 aggregates in dendroid shapes, E8minTBP was observed as linear 
and rectangular shapes, minTBPminTBP was observed to form liner shapes and 
minTBPminTBPE8 was observed as points dots across the titanium surface. 
The average of grey values of the surface of Ti6Al4V coated with five studied 
peptides and a PBS buffer control are shown in Figure 3.13. 
 
Figure 3.13: Mean grey value intensities of the entire surface of mirror finish polished 
Ti6Al4V of the five studied peptides and control. Error bars designate standard deviation 
for n = 3.  
 
Comparison of the grey values of the peptides with both titanium and HAP linker, 
coated these two surfaces are shown in Figure 3.14. The surface of HAP showed much 























Figure 3.14: Mean grey value intensities of peptides on both HAP and Ti6Al4V surfaces. 
Error bars designate standard deviation for n = 3. 
3.3.3 Fluorescence microscopy imaging of peptides coated on 
the carbide paper polished and hydrogen peroxide treated 
Ti6Al4V. 
Surfaces of Ti6Al4V polished with the carbide paper as well, or with H2O2, were also 
coated with peptides: minTBP, minTBPE8, E8minTBP, minTBPminTBP, 
minTBPminTBPE8. Fluorescence imaging shows a uniform coating of the peptides on 
the surface. On the surfaces of carbide paper polished titanium the distribution of the 
peptides is uniform with the visible holes which were not removed during polishing. 
Uniform peptide coverage is also found on the surface of the H2O2 treated Ti6Al4V with 
porous surface topography. The pores were created with the hydrogen peroxide through 
a process, which is well described in the literature [48]. This unequal surface causes the 
attached peptides to be at different levels. For the regions where the peptide is attached 


















sensitive than at the higher surface planes where the camera records the intensity as 
higher. 
  
Figure 3.15:Ti6Al4V surface immersed in the PBS buffer control: a) carbide paper 
polished Ti6Al4V, b) hydrogen peroxide treated. 
 
  
Figure 3.16: Ti6Al4V surface coated with minTBP but with different surface pre-treatment: 












Figure 3.17: Grey value distribution of minTBP peptide coated on the surface of a) mirror 










Figure 3.18: Ti6Al4V surface coated with minTBPE8 but with different surface 





Figure 3.19: Grey value distribution of minTBPE8 peptide coated on the surface of a) 
mirror finish polished Ti6Al4V, b) carbide paper polished Ti6Al4V and c) hydrogen 











Figure 3.20: Ti6Al4V surface coated with E8minTBP but with different surface pre-




Figure 3.21: Grey value distribution of E8minTBP peptide coated on the surface of a) 
mirror finish polished Ti6Al4V, b) carbide paper polished Ti6Al4V and c) hydrogen 










Figure 3.22: Ti6Al4V surface coated with minTBPminTBP but with different surface pre-





Figure 3.23: Grey value distribution of minTBPminTBP peptide coated on the surface of a) 
mirror finish polished Ti6Al4V, b) carbide paper polished Ti6Al4V and c) hydrogen 









Figure 3.24: Ti6Al4V surface coated with minTBPminTBPE8 but with different surface pre-
treatment: a) carbide paper polished Ti6Al4V, b) hydrogen peroxide treated.  
 
 
Figure 3.25: Grey value distribution of minTBPminTBPE8 peptide coated on the surface of 
a) mirror finish polished Ti6Al4V, b) carbide paper polished Ti6Al4V and c) hydrogen 







The aggregates of peptide, which were observed for the surface of titanium polished 
to mirror finish, were not observed on Ti6Al4V polished with carbide paper 400 grit 
polished or on peroxide treated titanium alloy substrate.  
Intensity grey values do not differ significantly between one peptide sequence and 
another with the exception of minTBP which intensity is twice as large as the rest of the 
peptides. (Figure 3.26) 
Hydrogen peroxide treated titanium alloy on the other hand shows that the greatest 
intensity for the minTBPminTBP peptide followed by minTBP alone. The minTBPE8 and 
minTBPminTBPE8 showed similar values of the intensity. The intensity of E8minTBP on 
the surface of hydrogen peroxide treated Ti6Al4V is not significantly different than the 
one of a buffer which means that there was no peptide coating present.  
 
Figure 3.26: Surface of Ti6Al4V coated with peptide: blue – mirror finish polished, red 


























3.4 Release of peptides from HAP and Ti6Al4V surfaces at 
different temperatures 
The amount of peptide released from surfaces of HAP or Ti6Al4V into the solution 
were analysed at three different temperatures 24 oC, 37 oC, and 44 oC but with a 
constant pH 7.4. These three temperatures are similar to those experienced in the body 
during post-surgery conditions such as elevated temperature during infection and 
healing process.[49]  
3.4.1 Temperature dependent release of peptides from the 
surface of HAP 
Release patterns of peptide sequences from the surface of HAP at three different 
temperatures are shown in Figure 3.27. The rate of the release of the peptides is 
summarized in the Table 3.3. 
Table 3.3: Release rate of peptides from the surface of hydroxyapatite at different 
temperatures, n = 3. 
Peptide sequence 
Rate of release at 
24 OC [units/s] 
Rate of release at 
37 OC [units/s] 
Rate of release at 
44 OC [units/s] 
E8 (2.12 ± 0.05) x 10-5 (3.65 ± 0.06) x 10-5 (3.26 ± 0.06) x 10-5 
minTBPE8 (3.74 ± 0.08) x 10-5 (4.27 ± 0.04) x 10-5 (4.38 ± 0.04) x 10-5 
E8minTBP (3.74 ± 0.07) x 10-5 (4.27 ± 0.05) x 10-5 (3.26 ± 0.05) x 10-5 








Figure 3.27: Release of peptide sequences from the surface of HAP at 24 oC (blue) , 37 oC (green) and 44 oC (red); a) E8, b) 






























































































3.4.2 Temperature dependent release of peptides from the 
surface of Ti6Al4V. 
Release patterns of peptides from the surface of Ti6Al4V at temperatures: 24 oC, 
37 oC and 44 oC are summarized in Figure 3.28. The rates of release for the studied 
peptides are summarized in Table 3.4. 
Table 3.4: Release of peptides from the surface of Ti6Al4V at different temperatures, n = 3. 
Peptide 
Rate of release at 
24 OC [units/s] 
Rate of release at 
37 OC [units/s] 
Rate of release at 
44 OC [units/s] 
minTBP 2.02 ± 0.06  x 10-5 4.97 ± 0.07 x 10-5 2.85 ± 0.06 x 10-5 
minTBPE8 0.83 ± 0.07 x 10-5 4.50 ± 0.04 x 10-5 4.05 ± 0.05 x 10-5 
E8minTBP 1.70 ± 0.06 x 10-5 3.91 ± 0.07 x 10-5 1.37 ± 0.07 x 10-5 
minTBPminTBPE8 2.75 ± 0.05 x 10-5 3.72 ± 0.05 x 10-5 0.71 ± 0.05 x 10-5 








Figure 3.28: Release of peptide sequences from the surface of Ti6Al4V at 24 oC (blue), 37 oC (green) and 44 oC (red), a) 
minTBP, b) minTBPE8, c) E8minTBP, d)minTBPminTBPE8, e) minTBPminTBP. Error bars designate standard deviation for 
































































































Figure 3.28 Continuation: Release of peptide sequences from the surface of Ti6Al4V at 24 oC (blue), 37 oC (green) and 44 oC 
(red), a) minTBP, b) minTBPE8, c) E8minTBP, d)minTBPminTBPE8, e) minTBPminTBP. Error bars designate standard 



























3.5 Release studies of the peptides from surfaces of HAP 
and Ti6Al4V at different pH values 
The influence on how fast studied peptide molecules are released from the surfaces 
of Ti6Al4V and HAP at different pH values was tested at the same temperature (37 oC). 
The pH values 5.2, 7.4 and 10.0 were chosen to mimic body conditions during the 




3.5.1 Release studies of peptides from surface on HAP at 
different pH values. 
Release pattern of peptides from the surface of HAP at pH values: 5.2, 7.4 and 10.0 
is shown in . The rates of the release of the studied peptides from the surface of HAPV 
are summarized in Table 3.5. 
Table 3.5: Release of peptides from the surface of HAP at pH 5.2, 7.4 and 10.0,n = 3. 
Peptide sequence 
Release rate at pH 5.2 
[units/s] 
Release rate at pH 7.4 
[units/s] 
E8 (3.59 ± 0.06) x 10-5  (4.08 ± 0.05) x 10-5 
minTBPE8 (4.24 ± 0.06) x 10-5 (4.11 ± 0.04) x 10-5 
E8minTBP (4.41 ± 0.08) x 10-5 (5.09 ± 0.04) x 10-5 






Figure 3.29: Release peptide sequences from the surface  of HAP at pH of 5.2 (red), 7.4 (green) and 10.0 (blue); a) E8, b) 


























































































3.5.1 Release studies of the peptides from the surface of Ti6Al4V 
at different pH values 
Release pattern of peptides from the surface of Ti6Al4V at pH values: 5.2, 7.4 and 
10.0 is shown in . The rates of the release of the studied peptides from the surface of 
Ti6Al4V are summarized in . 
Table 3.6: Release of peptides from the surface of Ti6Al4V mirror finish polished plates at 
pH 5.2, 7.4 and 10.0 values, n = 3. 
Peptide sequence 
Release rate at 
pH 5.2 [units/s] 
Release rate at 
pH 7.4 [units/s] 
Release rate pH 
10.0 [units/s] 
minTBP (4.96 ± 0.07) x 10-5  (4.14 ± 0.04) x 10-5  (1.06 ± 0.06) x 10-5  
minTBPminTBP (4.60 ± 0.06) x 10-5  (2.14 ± 0.04) x 10-5  (1.35 ± 0.07) x 10-5  
minTBPE8 (3.95 ± 0.06) x 10-5  (2.73 ± 0.07) x 10-5  (1.06 ± 0.06) x 10-5  
E8minTBP (3.94 ± 0.08) x 10-5  (2.71 ± 0.04) x 10-5  (2.43 ± 0.05) x 10-5  







Figure 3.30: Release of peptide sequences from the surface of Ti6Al4V at pH 5.2 (green), 7.4 (red) and 10.0 (blue); a) minTBP, 
































































































: Continuation: Release of peptide sequences from the surface of Ti6Al4V at pH 5.2 (green), 7.4 (red) and 10.0 (blue); a) 
minTBP, b) minTBPE8, c) E8minTBP, d) minTBPminTBPE8, e) minTBPminTBP. Error bars designate standard deviation for 
































4.1 Solid Phase Peptide Synthesis 
4.1.1 Purity of the Solid Phase Peptide Synthesis 
The Fmoc protection group as well as the resin allow for the SPPS to give high purity 
of the sequence as well as good overall yield. Considering that the purity of the 
purchased amino acids is >98%, it can be assumed that the yield of each coupling step 
is at least 0.98 and the final theoretical purity of the product should be at least 0.98x 
where x is the amount of amino acids in the sequence. For example, the theoretical 
purity for the 6-amino acid peptide sequence should be 88% whereas for 8-amino acid 
peptide sequence the theoretical purity of the product should be 85% and 9-amino acid 
peptides theoretical purity should be 83% and for 17-amino acid peptide sequence the 
theoretical purity should be 71%.  
Purity of the peptides synthesized in this research was as expected dependant on the 
length of the sequence. Products of longer sequences were less pure than the one of 
the shorter sequences (see Table 3.1).  
4.2  Fluorescence microscopy of the FITC labelled peptides 
coated on the surfaces of HAP and Ti6Al4V. 
As described earlier, peptide aptamers are able to establish electrostatic 
interactions with inorganic surfaces. In this research peptides which bind to the surfaces 
of HAP and titanium were observed on the surfaces of this calcium phosphate and of 
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titanium alloy as designed. The peptides were designed in different N and C terminal 
arrangement as the presence of one or another end might influence adhesion. The 
peptide containing two titanium binding sequences was also used as double in the 
sequence as multiplicity might increase binding of the peptide molecules to the titanium 
surface. 
One of the common techniques to prove that the surface of inorganic substrate is 
coated with the peptide molecules is to label the biomolecules with the fluorochrome 
such as FITC and then observe the surface under confocal fluorescence microscope. 
FITC light absorption maximum is at 494 nm and its emission maximum at 521 nm. This 
molecule is orange in colour in the visible light and it emits green fluorescence light 
when subjected to the UV light illumination of in example fluorescence microscope. The 
labelling of the biomolecule with FITC is based on establishing a covalent bond between 
the isothiocyanate group and an amine of either protein or peptide.  
4.2.1 Fluorescence microscopy of HAP coated with FITC labelled 
peptides 
Negatively charged proteins of ECM are able to nucleate and template 
hydroxyapatite formation.[1] Investigation of the sequences of these proteins led to the 
discovery of many peptides sequences which are able to establish electrostatic 
interactions with this calcium phosphate.[50] The E8 sequence is derived from the bone 
sialoprotein and its HAP binding ability has been widely studied and described in the 
literature.[23] The previous research shows that it is able to sustain its function when it 
is alone as well as when it is conjugated with another peptide such as RGD.[25] Our 
fluorescence studies are consistent with the previous finding that this sequence can 
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bind HAP crystals. The binding was observed for both E8 sequence alone as well as for 
the E8 sequences conjugated to the minTBP peptide. In this research the E8 peptide 
was coupled to minTBP peptide, which binds to the titanium, through both N- and C- 
terminus, respectively and was also used on its own as a positive control. 
FITC labelled peptides: E8, minTBPE8, E8minTBP and minTBPminTBPE8 coated on 
HAP were proven to bind to this material by showing significant amount of fluorescence 
on the surface coated with the peptides in relation to the one obtained from images of 
buffer control. (Figure 3.1 - Figure 3.5) The images as well as grey value intensity 
showed uniform distribution of peptides.  
The comparison of different intensities of the FITC fluorescence showed that the 
addition of the titanium binding peptide decreases the amount of peptide coated on the 
surface. This is due to lengthening the sequence gives more mobility to the peptide and 
because of this the molecule will bind in a lesser extent. The minTBPE8 and E8minTBP 
have different values which indicate that N-terminal or C-terminal location of E8 
sequence has an influence on the peptides ability to bind to the HAP surface. Smaller 
intensities were seen for the E8 located at N-terminus which points out that presence of 
carboxylic acid of the C-terminal takes part in the binding to HAP.  
4.2.2 Fluorescence microscopy of Ti6Al4V coated with FITC 
labelled peptides 
Titanium is not a natural mineral found in the body so the sequences, which means 
that nature did not equipped the human body with a protein which would be able to 
serve as the binder. The minTBP peptide was found artificially as described before by 
Sano and Shiba.[8] This peptide sequence similarly to the E8 peptide was used as a 
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positive control to monitor the change of adsorption of the peptides on the titanium alloy 
when coupled to a HAP binding domain. FITC fluorescence has been observed using 
confocal microscopy for all peptide sequences: minTBP, minTBPminTBP, minTBPE8, 
E8minTBP and minTBPminTBPE8 peptide molecules, on the surface of mirror finish 
polished, carbide paper grit 400 polished and hydrogen peroxide treated Ti6Al4V. The 
distribution of the peptide molecules on the surface of the polished to the mirror finished 
titanium was not uniform while the rest of the surface treatment gave equal distribution 
of molecules across the surface.  
In literature, it has been shown that the metallic surface has more hydrophobic 
character when it is smoother.[51] Peptides and proteins can be either hydrophobic or 
hydrophilic so the hydrophobicity of the surface can change the way they arrange when 
in contact. MinTBP-1 has half hydrophobic (L, P, A) and half hydrophilic (R, K, D) amino 
acids while E8 has only hydrophilic amino acids, the mirror finish polishing gives a very 
smooth and by this more hydrophobic surface. It is possible that hydrophilic amino acids, 
upon first contact with the hydrophobic surface, cause peptide to create clusters which 
are observed in this research. When the surface becomes rougher the hydrophobic 
character is decreased and then the peptides hydrophobic interaction with the surface is 
decreased and the clusters are not formed. MacDonald et. al. have found that the 
increase of the surface roughness of the commercially pure titanium decreased the 
amount of the attached protein such as fibronectin on the surface and that the protein 
was coated on these metallic substrate in form of a small compact clusters.[51] 
Deligianni et. al., observed similar pattern where fibronectin attachment to the rougher 
surface of Ti6Al4V (Ra = 0.874 µm) was less by 50 % than on the of the smoother 
64 
 
surface (Ra = 180 µm), unfortunately they did not record a distribution of this protein on 
the surface.[52] Fibronectin is built of greater amount of amino acids than the peptides 
used in this research but it is adsorbed on the surface of titanium by electrostatic 
interaction between its charged amino acids and the surface. This suggests that the 
hydrophilic character of the titanium surface created by different surface roughness 
might affect the behaviour of these peptides in similar manner and this is why the 
clusters were seen on mirror finish polished titanium but not on the carbide paper 
polished Ti6Al4V or hydrogen peroxide treated surface.  
Formation of crystal like shapes on mirror finisher Ti6Al4V could be due to the salt 
formation of the peptides with the buffer solution or with the peptide itself. PBS buffer 
has phosphate, sodium and chloride ions which can interact with the charged peptide 
amino acids and would crystallize when the surface is air dried. The second possibility 
is that these crystals like structures are the representation of the intermolecular 
aggregation. The negative charges of one peptide can interact with the positive charges 
of the second peptide creating clusters of molecules. These clusters later on interact 
with the surface and as the water evaporates crystals of peptide salts are formed. Both 
of these possibilities should be further investigated. HAP surface as well as carbide 
paper polished and hydrogen peroxide treated Ti6Al4V surfaces did not show the 
crystallization pattern and the distribution was uniform for all of the peptides, even 
though on images of surface of hydrogen peroxide treated titanium alloy substrate some 
spherical clusters are present but they might be due to the pore formation. The peroxide 
surface treatment causes the surface to be porous and it is possible that the aggregates 
are inside of the pores and can be seen as the depth differences. The assumption that 
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the porous surface is changing the crystal formation can be also used for the carbide 
treated Ti6Al4V and hydroxyapatite. 
Comparing the intensities of the clusters, the mean and the background, 
fluorescence show different variation between the intensities. The minTBPminTBP 
showed the greatest mean intensity which is an indication that this peptide is present in 
the greatest amount on the surface of Ti6Al4V. This would also be expected as the 
multiplicity of Ti binding peptide sequence domains should lead to better binding due to 
more sites for the binding.  
The intensities of the peptides on mirror finish polished, carbide paper polished and 
hydrogen peroxide treated surfaces in general show no significant difference between 
the three treatments used with the exception of minTBP peptide on carbide paper 
polished surface and the E8minTBP peptide on the hydrogen peroxide treated 
Ti6Al4V.(Figure 3.26 ) In the first case the amount of molecules is twice as much as for 
the other surface treatment. As discussed earlier increases surface roughness changes 
increases the hydrophilic character of the surface, it is possible that this change affects 
the minTBP as it has 50 % of hydrophobic and 50 % of hydrophilic amino acid in the 
sequence. In the second case, intensity of the peptide coated surface does not differ 
significantly from the buffer treated one, which means that there is no peptide present 
on the surface. The change of surface chemical composition due to peroxide treatment 
didn’t change the interaction of other peptide sequences with the Ti6Al4V, it is possible 
that the amino acid binding site location become unfavourable for this particular peptide 
sequence. These two observations should be further investigated to fully understand the 
reason behind them. 
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Comparing the intensity of HAP and Ti6Al4V bounded FITC labelled peptides it can 
be noticed that the HAP has significantly greater amount of molecules on the surface 
(Figure 3.14). This could be explained by the fact that HAP discs produced in this 
research are porous and this will cause the peptide to be absorbed in greater amount 
then in case of titanium. This would cause molecules bound to HAP to show a greater 
intensity than the one on the surface of Ti6Al4V which only exposes the top layer for 
binding. Another explanation would be that the binding ability of the E8 peptide is much 
greater than the one of the minTBP. The HAP binding domain has eight glutamic acids 
in its sequence each of which capable of electrostatic interaction with the calcium ions, 
minTBP on the other hand is known to use only arginine and aspartic acid to establish 
bonding and they use localized charges at a specific location on the surface. The 
difference in amount of binding sites and the specificity of target suggests that the E8 
peptide would establish stronger binding than minTBP does, causing the observed 
amount of peptides on the HAP to be much greater than the one on Ti6Al4V.  
It can be observed that two additional minTBP peptides significantly decrease the 
binding of this molecule on the surface of HAP, while increasing its binding on titanium 
as intended. This is due to the fact that there is only one HAP binding domain in the 
longest peptide and the additional weight and molecular mobility caused by the 
conjugation of other domain, leads to a loss in stability of the binding and weaker 
adsorption on the surface. On the other hand the minTBPminTBPE8 binding domain 
amount increases making it more stable on the surface of titanium. The multiplicity of 
the minTBP and the strengthening of its binding have been already observed by 
Kashiwagi et. al. In his research he encoded one two and three minTBP on the BMP-1 
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protein and found that with the amplifying of number of this peptide the binding of this 
protein to titanium surface was strengthened.[18] 
4.3 Release of peptides at different temperatures and pH 
conditions 
Average body temperature is 37 oC. However during infections body temperature is 
very often higher which is a natural defence mechanism of organism against microbes 
[49]. Temperatures measured close to the skin on the other hand can be a couple of 
degrees lower than the inner temperature as it is in constant contact with the 
temperature of an environment [49]. It is well known that under higher temperatures 
molecules show more movement than at lower ones.[53] When the peptide is 
electrostatically attached on the surface of inorganic material the movements of the 
molecule will cause it release. The more movement there is the sooner the peptide will 
detach from the surface so increase in the temperature should lead to increase in the 
molecules release. Many research groups are focusing on the thermally responsive 
peptides for drug delivery as small shift of temperature can change the interactions 
between the peptide molecules, drug transported and the surface on which they are 
attached.[28, 54-56] 
Similarly to the temperature variation the pH values can differ in the body. After 
surgery the pH of the wound can be changed due to the trauma. pH at implant insertion 
site can drop to as low as the and can be elevated to around 10 when the immune 
system is fighting the bacterial infection.[49] These acidic and alkaline conditions can 
change the behaviour of inorganic materials inserted in to the body as well as of the 
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biomolecules, which coat them. It is well known that the HAP is stable above pH 7.4. [57] 
However, when the pH is lowered the HAP begins to change into other forms of calcium 
phosphate such as brushite and it starts too dissolute.[58]  
Metals on the other hand can begin to corrode under acidic conditions. Titanium has 
a very good resistance to the corrosion because it develops a passivation layer. The 
new formed layer of oxide prevents it from dissolving. [48, 59] In aqueous solutions the 
titanium top passivation layer is modified to form titanium hydroxide groups which can 
later weakly react with water molecules creating a positively and negatively charged 
hydro-complexes.[48] The change in positive and negative units on the surface can 
have an influence on the electrostatic binding of biomolecules. The pH changes the 
protonated and deprotonated state of peptides, which may perturb or enhance 
electrostatic interactions. PKa values of the amino acids side chains of peptides 
designed for this research are summarized in Table 4.1. 
Table 4.1: pKas of the amino acids side chain groups found in minTBP and E8 sequences. 
Amino acid Amino acid pKa of side chain 
Aspartic acid, D 3.9 
Glutamic acid, E 4.1 
Lysine, K 10.7 
Arginine, R 12.5 
 
The conditions which were designed in this research are pH of 5.2, 7.4 and 10.0. This 
pH values do not cross the bounders of the charged state of any of the amino acids 
present and should not affect the peptide binding.  
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In this research release of all of the peptides from both HAP and Ti6Al4V at all tested 
conditions, showed very rapid release rate right after the immersion of the peptide 
coated surface in the buffer solution. After 2-3 hours the rate of the release slows down 
and small changes were observed. (Figure 3.27 - Figure 3.29) The only exception is the 
release of the peptide from HAP at pH 5.2 and it is discussed later in the Section 4.3.4. 
The release rate of the peptide from the surface was previously shown by Culpepper et. 
al. in their release study of E2DGEA, E4DGEA, E7DGEA and DGEA sequence from the 
allograft bone material.[60, 61] In their research they also observed rapid release of the 
peptides from the allograft particles which slowed down after 6 hours of study. They 
found that the oligoglutamic acid sequence containing peptides were retained on the 
surface of the allograft particles for 5 days while immersed in TBS, pH 7.4 and kept at 
37 OC. In addition they also found that the DGEA sequence, which does not have the 
specific binding ability to calcium phosphate was completely released after 24 h.[61] 
This suggests that the peptide might be retained on the surface of the inorganic material 
if it has a specific binding ability towards this material for longer period of time than 
when material non-specific peptide is used. In our research neither the surface of HAP 
nor the surface of Ti6Al4V was tested for fluorescence after the release study was 
performed so it is impossible to state if the peptide was fully release or if some fraction 
of the peptide was retained on the surface. These needs to be considered in the future 
by performing fluorescence imaging of peptide coated inorganic materials, which were 
previously immersed in the solution for minimum of 24 hours.  
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4.3.1 Release of peptides from the surface of HAP at different 
temperatures  
The release of peptides from the surface of HAP increases with increased 
temperature is summarized in the Table 3.3. There is a slight error in the measurements 
at 44 oC where by a mistake the temperature was raised between 4 and 5 h of 
measurements to 60 oC for 15 minutes. This change is reflected by the increase of 
release at 5 and 6 h measurements. The rate presented here is based on the first 4 
hours of measurements and might not be accurate as the amount of data points is 
based on five data points.  
For all of the peptides the release of molecules from the surface of HAP at 24 OC was 
always slower than the one for 37 OC. (see Table 3.3) This would be expected as 
temperature increase causes increase of the molecular movements which might further 
result in weakening of the electrostatic interaction with the surface. The rate of release 
at 44 OC was observed to be faster for minTBPE8 and minTBPminTBPE8 peptide 
sequences, which was expected. The release of E8 and E8minTBP molecules at 44 OC 
was not faster at higher temperature but this could be a result of the smaller data polls 
used to calculate the rates.  
The comparison of the rate of release for studied peptide sequences at 24 oC and 
37 oC were observed to be significantly faster for the minTBPE8 and E8minTBP than for 
the E8 and minTBPminTBPE8. This difference suggests that one minTBP conjugated 
with E8 have weakened the interaction of the E8 with the surface of HAP. The 
weakening of peptide and surface interaction due to the attachment of another molecule 
was earlier reported by Fujisawa.[62] What is interesting minTBPminTBPE8 peptide 
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molecules, which contain two titanium binding domains, were released much slower 
than minTBPE8 and E8minTBP. MinTBP has a negatively  aspartic acid in its sequence, 
Asp was previously shown to bind HAP but it interaction is weaker than the one of the 
Glu.[63] This suggests that there might be some interaction between the charged amino 
acid of minTBP with the HAP and that the proximity of the charges with the surface is 
favourable only when the titanium binding domain is in a specific distance from the HAP 
binding domain. The spatial arrangement of the peptide in relation to the surface was 
earlier observed to be an important factor of the peptide – surface interaction as when 
the molecule is not in a specific conformation the charges of amino acids will not be in a 
good proximity to the surface and the electrostatic interaction of peptide-surface will be 
limited.[11, 64] The not favourable arrangement of the Asp with the relation of the 
surface would explain why minTBPminTBPE8 have much more stable interaction in 
comparison to minTBPE8 and E8minTBP as another binding site is introduced for the 
longer molecule.  
The rate of release at 44 OC between the different peptide molecules is not consistent 
with the observation at the 24oC and 37 oC. The inconsistency can be caused by the 
error introduced while performing the test.  
4.3.2 Release of peptides from the surface of Ti6Al4V at different 
temperatures 
For all of the peptides the release of molecules from the surface of Ti6Al4V at 24 OC 
was always slower than the one for 37 OC. (see Table 3.4) This observation would be 
expected as temperature increase causes increase of the molecular movements which 
might further result in weakening of the electrostatic interaction with the surface. The 
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rate of release at 44 OC was observed to be the fastest only for the minTBPminTBP 
sequence. It was observed that for minTBPminTBPE8 and E8minTBP the release at 
this temperature was the slowest while for minTBP and minTBPE8 it was second 
slowest. This observation can be due to the earlier discussed error introduced in the 
measurements.  
The comparison of the release rate between peptide sequences three tested 
temperatures does not show a unique pattern for the molecules such as the one 
observed for surface of HAP.  
At 24 OC the rate of release from the slowest to the fastest was observed as follows: 
minTBPE8 < E8minTBP < minTBP < minTBPminTBPE8 < minTBPminTBP 
At 37 OC the rate of release from the slowest to the fastest was observed as follows: 
minTBPminTBPE8 < E8minTBP < minTBPE8 < minTBPminTBP < minTBP. 
At 44 OC the rate of release from the slowest to the fastest was observed as follows: 
minTBPminTBPE8 < E8minTBP < minTBP< minTBPE8 < minTBPminTBP. 
The titanium surface pH value have been reported to have more acidic character 
even though the positively charged hydro-complexes are present on the surface in 
aqueous solution,[30, 48, 65] this suggest that the surface of Ti6Al4V should repel 
negatively charged glutamic acids, leading to faster release of E8 containing peptides. 
This suggests that the minTBP and minTBPminTBP should bind to the surface the 
strongest and be released with the slowest rate.  
Release pattern of the molecules, which have different motifs at C and N terminals, 
shows that stability of the peptide on the surface depends on the termini location of E8 
and minTBP. At 24oC the release of minTBPE8 was higher while for the rest of 
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temperatures was slower release. This change in behaviour should be investigated. At 
24 oC the fastest release is recorded for minTBPminTBP and minTBPminTBPE8, which 
is interesting as these peptides have two titanium binding domains and in theory should 
bind the strongest on the surface of Ti6Al4V. At 37 oC release of the minTBPminTBPE8 
molecule is the slowest while the minTBPminTBP is still released faster than the rest of 
peptide sequences. At 44 oC the release of minTBPminTBPE8 is the slowest while the 
one of minTBPminTBP is the fastest. The multiplicity of the peptide has previously been 
proven to increase the binding ability of the sequence by Kashiwagi et. al. who showed 
that three minTBP peptides fused with Bone Morphological Protein significantly increase 
the binding in comparison with one.[18] Also in their studies of the different length 
oligoglutamic acid Culpepper et. al showed that the more repetition of the charged 
glutamic acid the stronger the binding is.[60] In this research his observation has been 
shown for the minTBPminTBPE8 with the exception of the data at 24 oC while is much 
different from the pattern observed for the minTBPminTBP.   
4.3.3 Release of peptides from HAP at different pH conditions 
As mentioned before HAP can undergo changes due to the change into a different 
calcium phosphate. HAP is known to be very stable at pH above 7.4 but at acidic pH, 
brushite which is a very soluble ceramic material, is the more stable form of calcium 
phosphate. This means that the calcium phosphate will slowly degenerate under acidic 
conditions. 
All of the peptides had similar release rates from the surface of HAP at both pH 7.4 
and at pH 10.0. This similar rate can imply that neither calcium phosphate nor the 
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peptides electrostatic binding properties were changed due to the different pH (Table 
3.5).  
At pH of 5.2 on the other hand, the concentration of released peptides was fluctuating 
from high to low values (see Figure 3.29). This change in the concentration of 
fluorescent molecules in the solution is observed for all of the peptides released from 
the HAP and can be due to the change of this ceramic material into the brushite. It is 
possible that as brushite is being dissolved new HAP is formed leading to adhesion of 
peptides back on the surface of the ceramic material. BSP and its oligoglutamic 
peptides are known to nucleate the hydroxyapatite crystals and to mature the 
amorphous calcium phosphate into the HAP.[27, 66, 67]  It has been proposed that the 
spatial arrangement of the peptide amino acids in relation to the surface is responsible 
for favouring HAP over other forms of calcium phosphate.[67]  It is possible that the E8 
domain has a preference to bind to HAP. This means that if the process of HAP to 
brushite transformation occurs and this calcium phosphate is dissolved together with the 
release of peptides, then the released biomolecules might attach back on the surface of 
HAP. This process should be further investigated. One possible way to research it 
would be by measuring the amount of calcium and phosphate released and analysing 
the surface of the calcium phosphate in terms of crystalline forms at a given time. This 
should be further related to the amount of the peptide molecules attached on the 
surface and released in the solution at each data point. 
At pH 5.2 the molecules release rate from the most slowly released to the fastest 
released was observed as follows: 




At pH 7.4 the molecules release rate from the most slowly released to the fastest 
released was observed as follows: 
minTBPminTBPE8 < E8 < minTBPE8 < E8minTBP 
At this pH values all of the molecules exhibit the same release in relation. What is 
interesting the doubling of the minTBP in the sequences caused minTBPminTBPE8 to 
be released slower than the E8 is released while the molecules with one titanium 
binding domain are released faster. These observations suggest that the minTBP is 
able to interact with the surface of HAP but it might need a special spatial arrangement 
of charged molecules, as described during the temperature dependent studies, for the 
attachment to be favourable. Another interesting observation is that release of the 
minTBPE8 is slower than the release of E8minTBP. In this case the arrangement of the 
E8 at the N – terminal is observed to be unfavourable and causes the molecule to be 
released faster. This could be explained by the shielding of the surface caused by 
FITCconjugated to the N-termini. FITC is a very bulky molecule and because of its size 
it can decrease the proximity of the E8 peptide with the surface especially if the binding 
peptide is on the same terminal as it is attached.[68] In this research the FITC shielding 
effect was reduced by addition of the Ahx spacer between the peptide molecule and the 
fluorochrom which has been previously reported by Jullian et. al. but its effect is not fully 
overwhelmed.[68] In previous studies done by Fujisawa on the molecules involving E7 
sequence at the N – terminal the FITC labelled molecules did not exhibit significant 
difference than the one without the label.[62] This might suggest that the E8 peptide is 
more affective binder at the C – terminal. If this is the case then it can be assumed that 
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the carboxylic acid at the terminal also takes part in the binding with HAP. This binding 
of the carboxylic terminal have been previously proposed by Roddick-Lanzilotta in his 
study of the glutamic acid attachment to the titanium. [10]  
4.3.4 Release of peptides from Ti6Al4V at different pH conditions 
The dissociation of the peptides form the Ti6Al4V shows a trend where in the acidic 
conditions all of the peptides dissociated much faster from the surface than in alkaline 
(Table 3.5). 
In aqueous solutions titanium top passivation layer is modified to form titanium 
hydroxide groups which can later weakly react with the water molecules creating 
positively and negatively hydro-complexes of titanium. [48] 
Ti-OH + H2O   [Ti-O]
- + H3O
+ 
Ti-OH + H2O   [Ti-(OH2)]
+ + OH- 
These charged hydro-groups are sites for electrostatic interaction of arginine and 
aspartic acid of minTBP,[25] which means that changing the amount of the hydroxide 
sites should alter the binding properties of the peptide and be directly related to the 
release of them from the surface. It has been reported that placing titanium in alkaline 
solution increases the amount of hydroxylated titanium as well as it will lead to 
production of greater amount of negatively charged hydrates.[48] The acidic conditions 
on the other hand lead to a decrease of the hydro-complexes by leaving only the 
uncharged oxide layer.[48] In our research the release rate of peptides was decreased 
as the pH value was increased, which is interesting result as the surface of titanium 
should become more negatively charged and should repell the negatively charged 
glutamic acid and aspartic acid. On the other hand the interaction of arginine with the 
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Ti6Al4V surface should be strengthened at alkaline conditions which might result in 
more stable binding and slower release. The pH change and the binding of positively 
charged amino acid: lysine was studied by the Roddick-Lanzilotta et. al.[9] In their 
research they found that the alkaline conditions does not change significantly the 
titanium binding ability of lysine till the pH value reaches its pKa value where this amino 
acid is fully deprotonated, but the change of the titanium surface charge did not affect 
the molecule interaction significantly.[9] The reason for our finding is not well 
understood and needs to be further investigated.  
At pH 5.2 the molecules release rate order from the most slowly released to the 
fastest released was observed as follows: 
minTBPminTBPE8 < E8minTBP ≤ minTBPE8 < minTBPminTBP < minTBP 
At pH 7.4 the molecules release rate order from the most slowly released to the 
fastest released was observed as follows: 
minTBPminTBP < E8minTBP ≤ minTBPminTBPE8 ≤ minTBPE8 < minTBP 
At pH 10.0 the molecules release rate order from the most slowly released to the 
fastest released was observed as follows: 
minTBP = minTBPE8 < minTBPminTBPE8 = minTBPminTBP < E8minTBP 
At pH 5.2 and 7.4 all of the molecules were released slower than the minTBP from 
the surface of Ti6Al4V, while at pH 10.0 minTBP was released the slowest. These could 
be explained by the fact that at basic pH surface of titanium has more negatively 
charged oxides than at acidic pH and neutral pH.[48] As the molecules with the E8 
domain have more negative character than the one of the minTBP they will be released 
more readly than the minTBP. It is also possible that the fast release of the minTBP 
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peptide in relation to the E8 conjugated ones is caused by the interaction of the glutamic 
acid with the surface of titanium  in addition to the interaction of the arginine and lysine. 
Roddick-Lanzilotta et. al have found that the glutamic acid interact with the surface at 
the neutral and acidic contitions.[10] If this interaction is present for our studied peptides 
then it is possible that the stability of molecules on surface would be increased with the 
addition of the glutamic acid domain and the peptides containg E8 peptide will be 




Chapter 5  
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5.  Conclusions and Future Work 
Peptide aptamers are small biomolecules made of amino acids which have the 
ability to bind towards organic and inorganic materials. They can bind to different 
surfaces via electrostatic interactions which form under mild aqueous conditions. 
Merging two different motifs each possessing different function could allow for two 
surfaces to be connected together. The peptides designed in this research possess a 
function of binding to the HAP and titanium, and were proven to be able to establish 
electrostatic interaction with these surfaces. However aqueous solution release studies 
at different pH values and temperatures and temperatures showed that the nature of the 
binding is very weak and that these peptides will not be able to serve as an organic 
binder between the two inorganic layers when in the body. The peptides would be 
released within the first 30 hours and the coating would not induce faster integration of 
the molecules on the surface of an implant. 
One possible way to overcome this is encoding of these sequences into proteins 
with multiple domains such as ferritin. This way the binding domains will exist in 
multiplicity and the bonding would be stronger. Another solution is to use covalent 
bonding between the inorganic surface and the organic peptide. Another thing which 
could be improved is the binding ability of minTBP. It is very weak in comparison with 
the strength of the E8 sequence and HAP adhesion. The titanium binding sequence 
should be modified or new sequence with higher affinity should be generated. 
The release of the molecules from the surface of HAP showed a very interesting 
behaviour and the mechanism at pH 5.2 where a fluctuation of released peptide 
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concentration was observed. This phenomenon should be investigated by analysing the 
change of the crystalline form of calcium phosphate each time the amount of peptide is 
analysed, together with fluorescence microscopy of the HAP surface at a given data 
point. The release of the peptide molecules at 7.4 and 10.0 pH values showed that the 
location of binding domain at C or N terminal might have an effect on the release 
behaviour of peptides. The temperature release of the molecules from the surface of 
HAP and Ti6Al4V showed that most of the studied peptides are released faster at 
higher temperature. It has also been shown that increasing the pH value causes the 
release rate of peptides from the surface of Ti6Al4V to be slower. 
Another interesting behaviour observed in this research was the aggregation of 
the crystal structures on the surface of the titanium. The reason whether the peptides 
are able to self-aggregate or if these peptides aggregate in crystals due to presence of 
buffer should also be looked at. Information of self-aggregation of biomolecules gives 
some more data on how the biomolecules are arranged into membranes, cells and 
tissues and maybe in the future use of this knowledge will allow creating artificial bone 
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6.1 Determination of the Secondary Structure by Circular Dichroism 
Spectroscopy  
Folding of the peptides into secondary structure was analysed by the Circular Dichroism 
Spectroscopy. All peptides were of dissolved to 100 μM concentration in the phosphate 
buffer pH 7.4. Peptides were measured inside the cuvette of the 1cm and 0.1cm light 
path length. The spectra were recorded as the comparison of the negative and positive 
areas at 195 nm, 212nm as well as the shape of the curves were tools to distinguish 
between b-sheet, a-helices and random coil conformation of peptides and proteins 
[39,40]. The shape of the curve recorded by the CD spectrophotometer (Figure 6.1) is 
consistent with the literature random coil curve shape. The values of Circular Dichroism 
at the wavelength around 195nm are negative and at the wavelength around 220 are 
positive again confirming the random coil conformation. These results are consistent for 





Figure 6.1: Circular Dichroism spectra of the peptides studied  E8: path length 0.1cm – 
dark blue; path length 1.0cm- red, minTBP: 0.1cm - green, 1.0 cm – purple; minTBP-E8: 
0.1 cm – light blue, 1.0cm - orange. 
6.2 Secondary Structure studies of peptide by the Circular 
Dichroism Spectroscopy 
Peptides aptamers use the electrostatic interactions of the charged amino acids to 
establish binding with the oppositely charged surfaces of inorganic and organic 
materials [23]. This means that the location of the charged amino acid in the peptide 
sequence can have a great influence on the binding with given substrate. The spatial 
orientation of peptides can be directed by their folding into secondary structures such as 
helices, sheets and random coils [27]. These structures are created when the hydrogen 




















unordered structure called random coil is the most common for the small peptides and it 
does not show any specific hydrogen bonding. Beta sheets are usually created when 
Tyr, Phe, Trp, Thr, Val, Ile are present in the peptide sequence, while the helices is 
observed when Met, Ala, Leu, Glu and Lys are present [69, 70] based on the amino 
acids residues in the sequence the E8 as well as minTBP-E8 have a propensity to 
adopt helical structure because they are made of the glutamic acids residues. Circular 
Dichroism Spectroscopy (CD) is commonly used technique to analyse if the secondary 
structures of peptides and proteins. In this technique light is circularly polarised, which 
allows to notice difference in between chiral molecules. All amino acids beside Glycine 
are chiral molecules and they absorb left polarized light differently than the right 
polarized light. This means also means that the proteins and peptides build from the 
amino acid will exhibit chirality, be optically active and can be analysed by the CD. It is 
well established that the secondary structures of peptides and proteins have distinct 




Figure 6.2: Circular Dichroism pattern of the helices - Yellow, sheet – blue and random 
coil – red. 
The difference in the pattern is observed because secondary structures would force the 
amide bond to assume π or π angle. This angle will direct which electrons of amide 
bond will absorb the light. The amide bond absorption spectra are observed for the 
wavelength of around 220 nm for n -> π* and the wavelength of around 190 nm for 
π -> π*. 
                                         
Figure 6.3: Representation of the angles of the peptide bond and the electron transition. 
Analysis of the wavelengths when the transition takes place showed that the peptide 
assumes the random coil structure when the spectrum is positive at the n -> π* (λ≈220) 
and negative at π -> π * (λ≈190) [69, 70]. Peptide is in a form of B-sheet when the 
values at π -> π * are negative and positive n -> π [69, 70].The coupling of the excitons 
is observed in case of a-helices so the π -> π * transition is observed twice and the 
characteristic values are positive at perpendicular excitons at π -> π *, negative for 
parallel excitons and π -> π * and negative at n -> π * [69, 70]. 
The secondary structures of the peptides which were synthesised in this research were 
described only for the oligoGlutamic acid. The sequence of polyGlu was observed to be 
dependent on the pH in which it is analysed. The structure of α-helices was observed 
at 8.0 pH and random coil was observed at 4.0 pH [11]. Another research analysed the 
SpSpEEEEEEE sequence[11], which has two negatively charged phosphoSerines (Sp) 
87 
 
at their N-terminal conjugated to the eight consequent Glutamic acid residues. In this 
research formation of helices was observed in the phosphate buffer with Calcium ions at 
pH 7.4 and at 36 oC. The addition of the positive Calcium ions changed the ionic 
strength of the solution. This change could influence the arrangement of the residues in 
the peptide molecule and induce helices.  
In this research, CD spectra of all the synthesized peptides were analysed in 100 mM, 
pH 7.4. The choice of pH is based on the average body pH of 7.4. The comparison of 
the CD spectra with the patterns of different secondary structures previously described 
(Figure 6.2) shows curve characteristic for the random coil for all of the peptides. Molar 
Circular Dichroism values are positive at n -> π* (λ≈220) and negative at π -> π* (λ≈190) 
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